Topics:
Genitourinary Cancers • Medical Oncology
When do you consider for first-line atezolizumab for metastatic bladder cancer?
Which patients do you consider to be chemotherapy-ineligible for the sake of this treatment decision? How strong does the contraindication need to be?
Answer from: Medical Oncologist at Academic Institution
I see these patients in 2 groups, "cisplatin-ineligible" or "chemotherapy-ineligible”.
In the “cisplatin- ineligible” group one may consider a carboplatin-based regimen (carboplatin plus gemcitabine or carboplatin plus taxol) or atezolizumab. In “chemotherapy-inel...
Sign in or Register to read more